CAS RN: 460751-69-3
N-Fmoc-5-methoxy-L-tryptophan
Product Availability
Choose a grade to view its available package options.
1 package records1 with current stock1 grade group
| Batch No. | Package | Availability | Warehouse | Inquiry |
| Batchno.20250928 |
100mg / 250mg / 1g / 5g |
Confirm by inquiry |
Shanghai, Shandong | Inquiry |
GET A QUOTE
Packaging options, recorded purity, stock quantity and ship-from location below are generated from the current factory data table for this CAS.
- Pack sizes on record: 0.1g, 0.25g, 1g, 5g, 10g, 25g
- Available purity: >96%
- Inventory rows with stock: 6
- Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 460751-69-3
| Pack Size |
Recorded Purity |
Available Qty |
Ship From |
Inquiry |
| 0.1g |
>96% |
5
In Stock
|
Hong Kong |
Inquiry |
| 0.25g |
>96% |
5
In Stock
|
Shanghai |
Inquiry |
| 1g |
>96% |
5
In Stock
|
Shanghai |
Inquiry |
| 5g |
>96% |
5
In Stock
|
Shenzhen |
Inquiry |
| 10g |
>96% |
5
In Stock
|
Hong Kong |
Inquiry |
| 25g |
>96% |
5
In Stock
|
Shanghai |
Inquiry |
460751-69-3 / 2-(9H-fluoren-9-ylmethoxycarbonylamino)-3-(5-methoxy-1H-indol-3-yl)propanoic acid
Standard CAS: 460751-69-3
Multi CAS: Yes
Basic Information
CAS
460751-69-3
Multi CAS
Yes
Molecular Formula
C27H24N2O5
Molecular Weight
456.500000
Exact Mass
456.168522
InChI
InChI=1S/C27H24N2O5/c1-33-17-10-11-24-22(13-17)16(14-28-24)12-25(26(30)31)29-27(32)34-15-23-20-8-4-2-6-18(20)19-7-3-5-9-21(19)23/h2-11,13-14,23,25,28H,12,15H2,1H3,(H,29,32)(H,30,31)/t25-/m0/s1
InChIKey
LOSXXKTXEHICBG-VWLOTQADSA-N
Computed Properties
Structural Parameters
Heavy atom count
34
Aromatic heavy atom count
21
Fraction Csp3
0.19
Rotatable bonds
7
H-bond acceptors
4
H-bond donors
3
Molar refractivity
128.18
TPSA
100.65
LogP / Solubility
WLOGP
4.71
MLOGP
4.18
XLogP3
4.7
Consensus LogP
4.53
Log S (ESOL)
-5.63
Class (ESOL)
Slightly soluble
Log S (Ali)
-6.7
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.38
Class (SILICOS-IT)
Insoluble
ADME
GI absorption
High
BBB permeant
No
P-gp substrate
Yes
CYP1A2 inhibitor
Yes
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.16
Drug-likeness / Medicinal Chemistry
Lipinski
Yes
Ghose
Yes
Veber
Yes
Egan
Yes
Muegge
Yes
Bioavailability score
0.55
Leadlikeness
No
Synthetic Accessibility
4